| Roche Pharma (Schweiz) AG - Mircera 250 ug / 0.3 ml, Injektionslösung in einer Fertigspritze |
| 57860 | | 06 | | Mircera 250 ug / 0.3 ml | | Injektionslösung in einer Fertigspritze | | B03XA03 | | Methoxy Polyethylene Glycol-Epoetin Beta | | 27.09.2007 | | |
|
| Composition |
| methoxy polyethylene glycol-epoetinum beta 250 µg, natrii sulfas anhydricus, natrii dihydrogenophosphas monohydricus, mannitolum, poloxamerum 188, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, methioninum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.62 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Methoxy Polyethylene Glycol-Epoetinum Beta | 250 µg |
| | BAG: Active Agent | Dose |
|---|
| Methoxy Polyethylene Glycol-Epoetinum beta | 250 mcg |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Mannitol | | | Sodium Dihydrogenophosphate Monohydrate | | | Sodium Sulfate Anhydrate | | | Poloxamer | 188 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | 0.3 ml | 450.70 | 506.60 | A | SL | Yes |
|
